

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.61560932 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 5.83370602 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 5.77553468 |
| 4 | viral transcription (GO:0019083) | 5.58252063 |
| 5 | translational termination (GO:0006415) | 5.38387954 |
| 6 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.33273955 |
| 7 | ATP synthesis coupled proton transport (GO:0015986) | 5.33273955 |
| 8 | ribosomal small subunit biogenesis (GO:0042274) | 5.31532604 |
| 9 | proteasome assembly (GO:0043248) | 5.04978458 |
| 10 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 5.02499240 |
| 11 | cotranslational protein targeting to membrane (GO:0006613) | 4.94307089 |
| 12 | protein targeting to ER (GO:0045047) | 4.92065859 |
| 13 | translational elongation (GO:0006414) | 4.88878311 |
| 14 | maturation of SSU-rRNA (GO:0030490) | 4.80736145 |
| 15 | protein localization to endoplasmic reticulum (GO:0070972) | 4.74205742 |
| 16 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.65317257 |
| 17 | respiratory electron transport chain (GO:0022904) | 4.65075611 |
| 18 | ribosomal large subunit biogenesis (GO:0042273) | 4.61160663 |
| 19 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.60643658 |
| 20 | electron transport chain (GO:0022900) | 4.54666570 |
| 21 | oxidative phosphorylation (GO:0006119) | 4.50725137 |
| 22 | translational initiation (GO:0006413) | 4.37772079 |
| 23 | DNA unwinding involved in DNA replication (GO:0006268) | 4.36512919 |
| 24 | protein maturation by protein folding (GO:0022417) | 4.30554577 |
| 25 | translation (GO:0006412) | 4.24431590 |
| 26 | regulation of mitochondrial translation (GO:0070129) | 4.21764173 |
| 27 | viral life cycle (GO:0019058) | 4.20488275 |
| 28 | cellular protein complex disassembly (GO:0043624) | 4.19323430 |
| 29 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.11259358 |
| 30 | termination of RNA polymerase III transcription (GO:0006386) | 4.00689560 |
| 31 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.00689560 |
| 32 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.94885985 |
| 33 | ribosome biogenesis (GO:0042254) | 3.82375648 |
| 34 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.81098373 |
| 35 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.80520418 |
| 36 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.80520418 |
| 37 | NADH dehydrogenase complex assembly (GO:0010257) | 3.80520418 |
| 38 | metallo-sulfur cluster assembly (GO:0031163) | 3.79165843 |
| 39 | iron-sulfur cluster assembly (GO:0016226) | 3.79165843 |
| 40 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.78822677 |
| 41 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.74191830 |
| 42 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.72730105 |
| 43 | establishment of integrated proviral latency (GO:0075713) | 3.70877798 |
| 44 | histone arginine methylation (GO:0034969) | 3.69335209 |
| 45 | protein complex biogenesis (GO:0070271) | 3.65113807 |
| 46 | formation of translation preinitiation complex (GO:0001731) | 3.64775059 |
| 47 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.62509314 |
| 48 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.61423975 |
| 49 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.60238844 |
| 50 | regulation of translational fidelity (GO:0006450) | 3.60062396 |
| 51 | protein complex disassembly (GO:0043241) | 3.59492243 |
| 52 | proline biosynthetic process (GO:0006561) | 3.58972428 |
| 53 | respiratory chain complex IV assembly (GO:0008535) | 3.58721221 |
| 54 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 3.55847981 |
| 55 | cellular component biogenesis (GO:0044085) | 3.55734348 |
| 56 | DNA replication initiation (GO:0006270) | 3.55532886 |
| 57 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.55355739 |
| 58 | establishment of protein localization to mitochondrion (GO:0072655) | 3.55326680 |
| 59 | protein targeting to mitochondrion (GO:0006626) | 3.54750445 |
| 60 | viral mRNA export from host cell nucleus (GO:0046784) | 3.53965403 |
| 61 | L-methionine salvage (GO:0071267) | 3.53566755 |
| 62 | L-methionine biosynthetic process (GO:0071265) | 3.53566755 |
| 63 | amino acid salvage (GO:0043102) | 3.53566755 |
| 64 | pseudouridine synthesis (GO:0001522) | 3.49368320 |
| 65 | macromolecular complex disassembly (GO:0032984) | 3.48048686 |
| 66 | telomere maintenance via recombination (GO:0000722) | 3.41949288 |
| 67 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 3.41492777 |
| 68 | nucleobase biosynthetic process (GO:0046112) | 3.40338947 |
| 69 | guanosine-containing compound biosynthetic process (GO:1901070) | 3.37736103 |
| 70 | GTP biosynthetic process (GO:0006183) | 3.36436215 |
| 71 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.35768028 |
| 72 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.33994338 |
| 73 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.32873071 |
| 74 | rRNA modification (GO:0000154) | 3.32437134 |
| 75 | purine nucleobase biosynthetic process (GO:0009113) | 3.31611760 |
| 76 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.30453688 |
| 77 | negative regulation of ligase activity (GO:0051352) | 3.30453688 |
| 78 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.30183477 |
| 79 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.29689061 |
| 80 | inner mitochondrial membrane organization (GO:0007007) | 3.26495650 |
| 81 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.26464646 |
| 82 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.24222838 |
| 83 | quinone biosynthetic process (GO:1901663) | 3.23494740 |
| 84 | ubiquinone biosynthetic process (GO:0006744) | 3.23494740 |
| 85 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.23037670 |
| 86 | glycine metabolic process (GO:0006544) | 3.22943223 |
| 87 | rRNA processing (GO:0006364) | 3.22645174 |
| 88 | protein targeting to membrane (GO:0006612) | 3.22583038 |
| 89 | peptidyl-arginine methylation (GO:0018216) | 3.22148914 |
| 90 | peptidyl-arginine N-methylation (GO:0035246) | 3.22148914 |
| 91 | protein localization to mitochondrion (GO:0070585) | 3.21930544 |
| 92 | rRNA transcription (GO:0009303) | 3.21859941 |
| 93 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.21799160 |
| 94 | ribosome assembly (GO:0042255) | 3.20919784 |
| 95 | CTP metabolic process (GO:0046036) | 3.20786196 |
| 96 | CTP biosynthetic process (GO:0006241) | 3.20786196 |
| 97 | mitotic chromosome condensation (GO:0007076) | 3.20770418 |
| 98 | pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208) | 3.20142471 |
| 99 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.19303252 |
| 100 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.19303252 |
| 101 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.19187609 |
| 102 | UTP biosynthetic process (GO:0006228) | 3.18069419 |
| 103 | DNA strand elongation (GO:0022616) | 3.17592193 |
| 104 | establishment of viral latency (GO:0019043) | 3.16880933 |
| 105 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.16443008 |
| 106 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.16443008 |
| 107 | UTP metabolic process (GO:0046051) | 3.16247622 |
| 108 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.15535304 |
| 109 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.15535304 |
| 110 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.15535304 |
| 111 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.14752182 |
| 112 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.14418605 |
| 113 | GDP-mannose metabolic process (GO:0019673) | 3.13676464 |
| 114 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.13599201 |
| 115 | transcription from mitochondrial promoter (GO:0006390) | 3.13374324 |
| 116 | chaperone-mediated protein transport (GO:0072321) | 3.13097534 |
| 117 | negative regulation of RNA splicing (GO:0033119) | 3.12242929 |
| 118 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 3.12207775 |
| 119 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.11403768 |
| 120 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.11072900 |
| 121 | L-serine metabolic process (GO:0006563) | 3.10993533 |
| 122 | L-phenylalanine metabolic process (GO:0006558) | 3.10192875 |
| 123 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.10192875 |
| 124 | folic acid metabolic process (GO:0046655) | 3.10035724 |
| 125 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.10016482 |
| 126 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.10016482 |
| 127 | rRNA metabolic process (GO:0016072) | 3.09686582 |
| 128 | spliceosomal snRNP assembly (GO:0000387) | 3.09464904 |
| 129 | negative regulation of mRNA processing (GO:0050686) | 3.09267158 |
| 130 | protein deneddylation (GO:0000338) | 3.08641978 |
| 131 | mitotic recombination (GO:0006312) | 3.08102437 |
| 132 | cullin deneddylation (GO:0010388) | 3.08056324 |
| 133 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.07206741 |
| 134 | pentose-phosphate shunt (GO:0006098) | 3.07195200 |
| 135 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.04064224 |
| 136 | DNA replication checkpoint (GO:0000076) | 3.02714750 |
| 137 | nuclear envelope reassembly (GO:0031468) | 3.01279368 |
| 138 | mitotic nuclear envelope reassembly (GO:0007084) | 3.01279368 |
| 139 | pentose metabolic process (GO:0019321) | 2.95283070 |
| 140 | protein complex localization (GO:0031503) | 2.91138336 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.33100671 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.13561006 |
| 3 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.92524012 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.79487777 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.60483067 |
| 6 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.50968205 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.42032654 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.36624164 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.25838877 |
| 10 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.17708372 |
| 11 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.17382914 |
| 12 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.95386807 |
| 13 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.90058704 |
| 14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.69336668 |
| 15 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.69010275 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.51092313 |
| 17 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.42616384 |
| 18 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.39546392 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.39525068 |
| 20 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.36289598 |
| 21 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.36108617 |
| 22 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.29950896 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.29476205 |
| 24 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.29417348 |
| 25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.27846275 |
| 26 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.14970898 |
| 27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.13350762 |
| 28 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.10460187 |
| 29 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.09680783 |
| 30 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.08694161 |
| 31 | * GABP_19822575_ChIP-Seq_HepG2_Human | 2.06308379 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.00542613 |
| 33 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.98173299 |
| 34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.96498903 |
| 35 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.95234353 |
| 36 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.95090826 |
| 37 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.91479654 |
| 38 | MYC_22102868_ChIP-Seq_BL_Human | 1.88369133 |
| 39 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.86813903 |
| 40 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.80856437 |
| 41 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.75681161 |
| 42 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67913905 |
| 43 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66972467 |
| 44 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58483933 |
| 45 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.57206617 |
| 46 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.55022606 |
| 47 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.52594861 |
| 48 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.48812303 |
| 49 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.47556708 |
| 50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.47384942 |
| 51 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.46848196 |
| 52 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.46635329 |
| 53 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46182449 |
| 54 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.43689455 |
| 55 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.41706633 |
| 56 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.40675990 |
| 57 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.38655038 |
| 58 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.38512311 |
| 59 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38424420 |
| 60 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.35558366 |
| 61 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.33679423 |
| 62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.32078002 |
| 63 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.31012378 |
| 64 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30058757 |
| 65 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.27297396 |
| 66 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.27284006 |
| 67 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.26896058 |
| 68 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.26200550 |
| 69 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24910275 |
| 70 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.21429336 |
| 71 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20847016 |
| 72 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.20462669 |
| 73 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.19969632 |
| 74 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.19891589 |
| 75 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19652487 |
| 76 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.17975249 |
| 77 | P68_20966046_ChIP-Seq_HELA_Human | 1.17654634 |
| 78 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.17278470 |
| 79 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.16995626 |
| 80 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16954046 |
| 81 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.16917048 |
| 82 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16790082 |
| 83 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.15987557 |
| 84 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.15336501 |
| 85 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.12304048 |
| 86 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.12177481 |
| 87 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.10222160 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08559771 |
| 89 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08079973 |
| 90 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.07948078 |
| 91 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05054553 |
| 92 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.04177674 |
| 93 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04013662 |
| 94 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.03961968 |
| 95 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.02785811 |
| 96 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.02372233 |
| 97 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01859902 |
| 98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01412675 |
| 99 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.01396158 |
| 100 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.01181902 |
| 101 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99771732 |
| 102 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.98597122 |
| 103 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98325799 |
| 104 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.98312253 |
| 105 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.97467064 |
| 106 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.97359859 |
| 107 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.97134246 |
| 108 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.97128042 |
| 109 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.95827172 |
| 110 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95288077 |
| 111 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.95185524 |
| 112 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.92711261 |
| 113 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.89390754 |
| 114 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.88517381 |
| 115 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.87340050 |
| 116 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.86666755 |
| 117 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.86002826 |
| 118 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84516372 |
| 119 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84077686 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 5.10151949 |
| 2 | MP0009379_abnormal_foot_pigmentation | 4.24330806 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.94598773 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.75649613 |
| 5 | MP0006036_abnormal_mitochondrial_physio | 3.62259406 |
| 6 | MP0003186_abnormal_redox_activity | 3.17823023 |
| 7 | MP0005360_urolithiasis | 3.01286865 |
| 8 | MP0004957_abnormal_blastocyst_morpholog | 2.96299861 |
| 9 | MP0005085_abnormal_gallbladder_physiolo | 2.76194474 |
| 10 | MP0009840_abnormal_foam_cell | 2.55908571 |
| 11 | MP0006035_abnormal_mitochondrial_morpho | 2.55320586 |
| 12 | MP0005332_abnormal_amino_acid | 2.46124045 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.42903979 |
| 14 | MP0005365_abnormal_bile_salt | 2.34217192 |
| 15 | MP0005083_abnormal_biliary_tract | 2.21775877 |
| 16 | MP0004185_abnormal_adipocyte_glucose | 2.17431823 |
| 17 | MP0003646_muscle_fatigue | 2.16600471 |
| 18 | MP0002877_abnormal_melanocyte_morpholog | 2.09020659 |
| 19 | MP0003195_calcinosis | 2.04998764 |
| 20 | MP0005501_abnormal_skin_physiology | 2.00880568 |
| 21 | MP0000350_abnormal_cell_proliferation | 2.00235395 |
| 22 | MP0002837_dystrophic_cardiac_calcinosis | 1.97133580 |
| 23 | MP0000678_abnormal_parathyroid_gland | 1.95217860 |
| 24 | MP0001764_abnormal_homeostasis | 1.94844256 |
| 25 | MP0010030_abnormal_orbit_morphology | 1.91898793 |
| 26 | MP0008932_abnormal_embryonic_tissue | 1.86504668 |
| 27 | MP0003718_maternal_effect | 1.82855476 |
| 28 | MP0003111_abnormal_nucleus_morphology | 1.82623511 |
| 29 | MP0005330_cardiomyopathy | 1.77799652 |
| 30 | MP0004233_abnormal_muscle_weight | 1.68000466 |
| 31 | MP0003077_abnormal_cell_cycle | 1.66994137 |
| 32 | MP0002796_impaired_skin_barrier | 1.66664362 |
| 33 | MP0008058_abnormal_DNA_repair | 1.61414642 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.61065244 |
| 35 | MP0005636_abnormal_mineral_homeostasis | 1.59599502 |
| 36 | MP0000749_muscle_degeneration | 1.56973303 |
| 37 | MP0000537_abnormal_urethra_morphology | 1.55949351 |
| 38 | MP0001666_abnormal_nutrient_absorption | 1.55514375 |
| 39 | MP0009643_abnormal_urine_homeostasis | 1.54805255 |
| 40 | MP0005319_abnormal_enzyme/_coenzyme | 1.54618882 |
| 41 | MP0002132_abnormal_respiratory_system | 1.54496167 |
| 42 | MP0003656_abnormal_erythrocyte_physiolo | 1.50758751 |
| 43 | MP0010094_abnormal_chromosome_stability | 1.47556309 |
| 44 | MP0003123_paternal_imprinting | 1.46864314 |
| 45 | MP0009672_abnormal_birth_weight | 1.46361643 |
| 46 | MP0004858_abnormal_nervous_system | 1.42949990 |
| 47 | MP0001727_abnormal_embryo_implantation | 1.42538667 |
| 48 | MP0002163_abnormal_gland_morphology | 1.38180862 |
| 49 | MP0000358_abnormal_cell_content/ | 1.35750121 |
| 50 | MP0001697_abnormal_embryo_size | 1.35571858 |
| 51 | MP0001672_abnormal_embryogenesis/_devel | 1.32830127 |
| 52 | MP0005380_embryogenesis_phenotype | 1.32830127 |
| 53 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.32629145 |
| 54 | MP0003705_abnormal_hypodermis_morpholog | 1.25474899 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.22686385 |
| 56 | MP0003221_abnormal_cardiomyocyte_apopto | 1.21247431 |
| 57 | MP0001881_abnormal_mammary_gland | 1.18248619 |
| 58 | MP0004019_abnormal_vitamin_homeostasis | 1.16595674 |
| 59 | MP0001529_abnormal_vocalization | 1.16508763 |
| 60 | MP0003984_embryonic_growth_retardation | 1.16241674 |
| 61 | MP0003315_abnormal_perineum_morphology | 1.15541212 |
| 62 | MP0003786_premature_aging | 1.14807805 |
| 63 | MP0005670_abnormal_white_adipose | 1.13250821 |
| 64 | MP0002249_abnormal_larynx_morphology | 1.12914806 |
| 65 | MP0003191_abnormal_cellular_cholesterol | 1.12736666 |
| 66 | MP0002269_muscular_atrophy | 1.12534040 |
| 67 | MP0008057_abnormal_DNA_replication | 1.12438274 |
| 68 | MP0000490_abnormal_crypts_of | 1.11391697 |
| 69 | MP0004147_increased_porphyrin_level | 1.11340413 |
| 70 | MP0005266_abnormal_metabolism | 1.10527203 |
| 71 | MP0002085_abnormal_embryonic_tissue | 1.09771455 |
| 72 | MP0004133_heterotaxia | 1.09151527 |
| 73 | MP0005666_abnormal_adipose_tissue | 1.08922194 |
| 74 | MP0001849_ear_inflammation | 1.08917159 |
| 75 | MP0003011_delayed_dark_adaptation | 1.08857154 |
| 76 | MP0002088_abnormal_embryonic_growth/wei | 1.07793486 |
| 77 | MP0005075_abnormal_melanosome_morpholog | 1.05185387 |
| 78 | MP0004043_abnormal_pH_regulation | 1.05002022 |
| 79 | MP0010307_abnormal_tumor_latency | 1.03611544 |
| 80 | MP0010329_abnormal_lipoprotein_level | 1.03495322 |
| 81 | MP0005220_abnormal_exocrine_pancreas | 1.03218461 |
| 82 | MP0009053_abnormal_anal_canal | 1.03021521 |
| 83 | MP0002396_abnormal_hematopoietic_system | 1.02794118 |
| 84 | MP0004142_abnormal_muscle_tone | 1.01641812 |
| 85 | MP0005623_abnormal_meninges_morphology | 1.01253090 |
| 86 | MP0001346_abnormal_lacrimal_gland | 1.01164618 |
| 87 | MP0005451_abnormal_body_composition | 1.01080182 |
| 88 | MP0001756_abnormal_urination | 1.00534435 |
| 89 | MP0008007_abnormal_cellular_replicative | 0.99976829 |
| 90 | MP0005076_abnormal_cell_differentiation | 0.99483772 |
| 91 | MP0003252_abnormal_bile_duct | 0.98924013 |
| 92 | MP0000747_muscle_weakness | 0.98472533 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.98412294 |
| 94 | MP0009278_abnormal_bone_marrow | 0.98256649 |
| 95 | MP0000750_abnormal_muscle_regeneration | 0.97535121 |
| 96 | MP0000003_abnormal_adipose_tissue | 0.97052714 |
| 97 | MP0000609_abnormal_liver_physiology | 0.96496740 |
| 98 | MP0006292_abnormal_olfactory_placode | 0.96060726 |
| 99 | MP0001853_heart_inflammation | 0.95852151 |
| 100 | MP0002160_abnormal_reproductive_system | 0.95839467 |
| 101 | MP0005384_cellular_phenotype | 0.95444240 |
| 102 | MP0000858_altered_metastatic_potential | 0.89764591 |
| 103 | MP0008872_abnormal_physiological_respon | 0.89588307 |
| 104 | MP0001730_embryonic_growth_arrest | 0.89384548 |
| 105 | MP0000681_abnormal_thyroid_gland | 0.89366252 |
| 106 | MP0004215_abnormal_myocardial_fiber | 0.85861089 |
| 107 | MP0005375_adipose_tissue_phenotype | 0.83810399 |
| 108 | MP0002118_abnormal_lipid_homeostasis | 0.83677326 |
| 109 | MP0000598_abnormal_liver_morphology | 0.83242236 |
| 110 | MP0008260_abnormal_autophagy | 0.82744692 |
| 111 | MP0001905_abnormal_dopamine_level | 0.82674088 |
| 112 | MP0000751_myopathy | 0.82650061 |
| 113 | MP0005376_homeostasis/metabolism_phenot | 0.80870652 |
| 114 | MP0000313_abnormal_cell_death | 0.80707223 |
| 115 | MP0008469_abnormal_protein_level | 0.79664910 |
| 116 | MP0010234_abnormal_vibrissa_follicle | 0.78855784 |
| 117 | MP0002086_abnormal_extraembryonic_tissu | 0.78815895 |
| 118 | MP0000049_abnormal_middle_ear | 0.78343062 |
| 119 | MP0004084_abnormal_cardiac_muscle | 0.78243794 |
| 120 | MP0001661_extended_life_span | 0.77538555 |
| 121 | MP0002084_abnormal_developmental_patter | 0.77460356 |
| 122 | MP0001986_abnormal_taste_sensitivity | 0.76984682 |
| 123 | MP0000703_abnormal_thymus_morphology | 0.76486345 |
| 124 | MP0005408_hypopigmentation | 0.76477656 |
| 125 | MP0009697_abnormal_copulation | 0.76151821 |
| 126 | MP0005621_abnormal_cell_physiology | 0.74753306 |
| 127 | MP0003763_abnormal_thymus_physiology | 0.74674173 |
| 128 | MP0005389_reproductive_system_phenotype | 0.73894224 |
| 129 | MP0005377_hearing/vestibular/ear_phenot | 0.73285431 |
| 130 | MP0003878_abnormal_ear_physiology | 0.73285431 |
| 131 | MP0008789_abnormal_olfactory_epithelium | 0.72890514 |
| 132 | MP0004036_abnormal_muscle_relaxation | 0.71700733 |
| 133 | MP0005165_increased_susceptibility_to | 0.71495161 |
| 134 | MP0008873_increased_physiological_sensi | 0.70594722 |
| 135 | MP0003137_abnormal_impulse_conducting | 0.70381237 |
| 136 | MP0001873_stomach_inflammation | 0.69214921 |
| 137 | MP0002111_abnormal_tail_morphology | 0.69214011 |
| 138 | MP0000627_abnormal_mammary_gland | 0.69170411 |
| 139 | MP0002080_prenatal_lethality | 0.69024731 |
| 140 | MP0003941_abnormal_skin_development | 0.68575960 |
| 141 | MP0002019_abnormal_tumor_incidence | 0.67808920 |
| 142 | MP0009642_abnormal_blood_homeostasis | 0.66750978 |
| 143 | MP0008995_early_reproductive_senescence | 0.66413115 |
| 144 | MP0000759_abnormal_skeletal_muscle | 0.66141078 |
| 145 | MP0002697_abnormal_eye_size | 0.65597149 |
| 146 | MP0003567_abnormal_fetal_cardiomyocyte | 0.65305839 |
| 147 | MP0000477_abnormal_intestine_morphology | 0.64207366 |
| 148 | MP0002970_abnormal_white_adipose | 0.63900893 |
| 149 | MP0004808_abnormal_hematopoietic_stem | 0.63827002 |
| 150 | MP0006276_abnormal_autonomic_nervous | 0.63627180 |
| 151 | MP0001348_abnormal_lacrimal_gland | 0.62189248 |
| 152 | MP0002210_abnormal_sex_determination | 0.61252709 |
| 153 | MP0003942_abnormal_urinary_system | 0.61189843 |
| 154 | MP0002098_abnormal_vibrissa_morphology | 0.60990562 |
| 155 | MP0005394_taste/olfaction_phenotype | 0.60951120 |
| 156 | MP0001919_abnormal_reproductive_system | 0.60110900 |
| 157 | MP0002751_abnormal_autonomic_nervous | 0.58959460 |
| 158 | MP0003638_abnormal_response/metabolism_ | 0.57933278 |
| 159 | MP0004145_abnormal_muscle_electrophysio | 0.57390720 |
| 160 | MP0001663_abnormal_digestive_system | 0.56822687 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatocellular necrosis (HP:0001404) | 5.34553411 |
| 2 | Hepatic necrosis (HP:0002605) | 5.23428135 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.05681405 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.94371675 |
| 5 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.82036202 |
| 6 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.82036202 |
| 7 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.70855203 |
| 8 | Acute encephalopathy (HP:0006846) | 4.61078120 |
| 9 | Increased CSF lactate (HP:0002490) | 4.56316941 |
| 10 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.47721449 |
| 11 | Abnormal number of erythroid precursors (HP:0012131) | 4.31163947 |
| 12 | Lipid accumulation in hepatocytes (HP:0006561) | 4.13847698 |
| 13 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.12242998 |
| 14 | Increased hepatocellular lipid droplets (HP:0006565) | 4.08768514 |
| 15 | Increased serum lactate (HP:0002151) | 4.04316393 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 3.95750287 |
| 17 | Lactic acidosis (HP:0003128) | 3.90957646 |
| 18 | Progressive macrocephaly (HP:0004481) | 3.84927743 |
| 19 | Increased muscle lipid content (HP:0009058) | 3.83456657 |
| 20 | Cerebral edema (HP:0002181) | 3.81338106 |
| 21 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.68129812 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.62309199 |
| 23 | Macrocytic anemia (HP:0001972) | 3.61861105 |
| 24 | 3-Methylglutaconic aciduria (HP:0003535) | 3.60659786 |
| 25 | Reticulocytopenia (HP:0001896) | 3.46074359 |
| 26 | Exercise intolerance (HP:0003546) | 3.34009345 |
| 27 | Renal Fanconi syndrome (HP:0001994) | 3.33991962 |
| 28 | Respiratory failure (HP:0002878) | 3.31792111 |
| 29 | Lethargy (HP:0001254) | 3.12033703 |
| 30 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.11629551 |
| 31 | Dicarboxylic aciduria (HP:0003215) | 3.11629551 |
| 32 | CNS demyelination (HP:0007305) | 3.07706827 |
| 33 | Abnormality of glycolysis (HP:0004366) | 3.04647812 |
| 34 | Increased serum pyruvate (HP:0003542) | 3.04647812 |
| 35 | Exertional dyspnea (HP:0002875) | 3.01324494 |
| 36 | Multiple enchondromatosis (HP:0005701) | 3.00899737 |
| 37 | Broad distal phalanx of finger (HP:0009836) | 2.96420809 |
| 38 | Emotional lability (HP:0000712) | 2.78400991 |
| 39 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.77282696 |
| 40 | Progressive muscle weakness (HP:0003323) | 2.76905338 |
| 41 | Hyperammonemia (HP:0001987) | 2.71961886 |
| 42 | Cerebral hypomyelination (HP:0006808) | 2.71701645 |
| 43 | Hyperglycinemia (HP:0002154) | 2.68670274 |
| 44 | Hyperglycinuria (HP:0003108) | 2.67596725 |
| 45 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.62814796 |
| 46 | Hyperthyroidism (HP:0000836) | 2.61151253 |
| 47 | Pallor (HP:0000980) | 2.60751624 |
| 48 | Oral leukoplakia (HP:0002745) | 2.54495287 |
| 49 | Abnormality of urine glucose concentration (HP:0011016) | 2.52549540 |
| 50 | Glycosuria (HP:0003076) | 2.52549540 |
| 51 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.52360649 |
| 52 | Abnormality of alanine metabolism (HP:0010916) | 2.52360649 |
| 53 | Hyperalaninemia (HP:0003348) | 2.52360649 |
| 54 | Rhabdomyolysis (HP:0003201) | 2.51081786 |
| 55 | Ragged-red muscle fibers (HP:0003200) | 2.50515700 |
| 56 | Respiratory difficulties (HP:0002880) | 2.50411987 |
| 57 | Selective tooth agenesis (HP:0001592) | 2.48602536 |
| 58 | Microvesicular hepatic steatosis (HP:0001414) | 2.48483431 |
| 59 | Abnormality of reticulocytes (HP:0004312) | 2.46893743 |
| 60 | Hypoglycemic coma (HP:0001325) | 2.46049401 |
| 61 | Generalized aminoaciduria (HP:0002909) | 2.45289909 |
| 62 | Breast hypoplasia (HP:0003187) | 2.44042587 |
| 63 | Nausea (HP:0002018) | 2.40044368 |
| 64 | Abnormality of glycine metabolism (HP:0010895) | 2.39225170 |
| 65 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.39225170 |
| 66 | Truncus arteriosus (HP:0001660) | 2.39179065 |
| 67 | Methylmalonic aciduria (HP:0012120) | 2.38046491 |
| 68 | Birth length less than 3rd percentile (HP:0003561) | 2.36174909 |
| 69 | Cholecystitis (HP:0001082) | 2.35134119 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.35134119 |
| 71 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.35031741 |
| 72 | Hyperphosphaturia (HP:0003109) | 2.33866391 |
| 73 | Leukodystrophy (HP:0002415) | 2.32322649 |
| 74 | Myopathic facies (HP:0002058) | 2.30938540 |
| 75 | Abnormality of the umbilical cord (HP:0010881) | 2.30794627 |
| 76 | Microretrognathia (HP:0000308) | 2.28885112 |
| 77 | Delayed CNS myelination (HP:0002188) | 2.27620871 |
| 78 | Optic disc pallor (HP:0000543) | 2.26869345 |
| 79 | Vertebral compression fractures (HP:0002953) | 2.24239691 |
| 80 | Abnormality of serum amino acid levels (HP:0003112) | 2.22509895 |
| 81 | Achilles tendon contracture (HP:0001771) | 2.20625670 |
| 82 | Type I transferrin isoform profile (HP:0003642) | 2.20500746 |
| 83 | Myoglobinuria (HP:0002913) | 2.19726502 |
| 84 | Palpitations (HP:0001962) | 2.18984656 |
| 85 | Ketosis (HP:0001946) | 2.18347093 |
| 86 | Reduced antithrombin III activity (HP:0001976) | 2.17015497 |
| 87 | Hypertensive crisis (HP:0100735) | 2.14909310 |
| 88 | Progressive external ophthalmoplegia (HP:0000590) | 2.14485603 |
| 89 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.14431935 |
| 90 | Rough bone trabeculation (HP:0100670) | 2.12064336 |
| 91 | Vomiting (HP:0002013) | 2.11883230 |
| 92 | Trismus (HP:0000211) | 2.09676608 |
| 93 | Abnormality of the tricuspid valve (HP:0001702) | 2.06652248 |
| 94 | Abnormality of renal resorption (HP:0011038) | 2.06020764 |
| 95 | Aplastic anemia (HP:0001915) | 2.05850934 |
| 96 | Hyperacusis (HP:0010780) | 2.05471312 |
| 97 | Megaloblastic anemia (HP:0001889) | 2.02805555 |
| 98 | Late onset (HP:0003584) | 2.02288826 |
| 99 | Hypobetalipoproteinemia (HP:0003563) | 2.01887463 |
| 100 | Ketoacidosis (HP:0001993) | 2.01448775 |
| 101 | Metabolic acidosis (HP:0001942) | 2.00522042 |
| 102 | Seborrheic dermatitis (HP:0001051) | 2.00034473 |
| 103 | Hypoparathyroidism (HP:0000829) | 1.95450398 |
| 104 | Squamous cell carcinoma (HP:0002860) | 1.95292352 |
| 105 | Testicular atrophy (HP:0000029) | 1.95049764 |
| 106 | Proximal tubulopathy (HP:0000114) | 1.94624192 |
| 107 | Abnormal hemoglobin (HP:0011902) | 1.93068737 |
| 108 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.92531693 |
| 109 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.92342304 |
| 110 | Single umbilical artery (HP:0001195) | 1.92342304 |
| 111 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.92342304 |
| 112 | Abnormal trabecular bone morphology (HP:0100671) | 1.91359778 |
| 113 | Delusions (HP:0000746) | 1.90995156 |
| 114 | Gliosis (HP:0002171) | 1.90867709 |
| 115 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.90807513 |
| 116 | Septate vagina (HP:0001153) | 1.90546058 |
| 117 | Chromsome breakage (HP:0040012) | 1.87830807 |
| 118 | Abnormality of the Achilles tendon (HP:0005109) | 1.87527545 |
| 119 | Carpal bone hypoplasia (HP:0001498) | 1.87253862 |
| 120 | Ileus (HP:0002595) | 1.85531811 |
| 121 | Fasciculations (HP:0002380) | 1.84831114 |
| 122 | Pancytopenia (HP:0001876) | 1.83844322 |
| 123 | Unsteady gait (HP:0002317) | 1.82514484 |
| 124 | Secondary amenorrhea (HP:0000869) | 1.82502437 |
| 125 | Abnormal number of incisors (HP:0011064) | 1.81148732 |
| 126 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.80912215 |
| 127 | Abnormal protein glycosylation (HP:0012346) | 1.80912215 |
| 128 | Abnormal glycosylation (HP:0012345) | 1.80912215 |
| 129 | Reticulocytosis (HP:0001923) | 1.79017520 |
| 130 | Hypokinesia (HP:0002375) | 1.77764201 |
| 131 | Cleft eyelid (HP:0000625) | 1.77642781 |
| 132 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.76235399 |
| 133 | Death in infancy (HP:0001522) | 1.75939461 |
| 134 | Premature ovarian failure (HP:0008209) | 1.74754646 |
| 135 | Gout (HP:0001997) | 1.72959025 |
| 136 | Degeneration of anterior horn cells (HP:0002398) | 1.72945512 |
| 137 | Abnormality of the anterior horn cell (HP:0006802) | 1.72945512 |
| 138 | Hypergonadotropic hypogonadism (HP:0000815) | 1.70067134 |
| 139 | Horseshoe kidney (HP:0000085) | 1.68467368 |
| 140 | Petechiae (HP:0000967) | 1.67737484 |
| 141 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.67492582 |
| 142 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.66973631 |
| 143 | Opisthotonus (HP:0002179) | 1.64478923 |
| 144 | Sparse eyelashes (HP:0000653) | 1.62329198 |
| 145 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.62253994 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.70935533 |
| 2 | NME2 | 4.52281973 |
| 3 | BCKDK | 4.03061310 |
| 4 | VRK2 | 3.77498926 |
| 5 | EIF2AK1 | 3.62689685 |
| 6 | STK16 | 3.55629426 |
| 7 | TESK2 | 3.37053979 |
| 8 | TLK1 | 3.15936786 |
| 9 | TRIB3 | 3.11561494 |
| 10 | WEE1 | 3.04400311 |
| 11 | ARAF | 2.98010362 |
| 12 | SMG1 | 2.96858129 |
| 13 | PIM2 | 2.84866505 |
| 14 | NME1 | 2.66544294 |
| 15 | MAP3K11 | 2.32336046 |
| 16 | IRAK3 | 2.03398161 |
| 17 | SRPK1 | 2.01088666 |
| 18 | EIF2AK3 | 1.97792745 |
| 19 | KDR | 1.87699287 |
| 20 | BRAF | 1.83740006 |
| 21 | EEF2K | 1.70103929 |
| 22 | VRK1 | 1.57071727 |
| 23 | MAPKAPK3 | 1.40330383 |
| 24 | DYRK3 | 1.38004063 |
| 25 | ICK | 1.30621302 |
| 26 | LMTK2 | 1.24660459 |
| 27 | ABL2 | 1.24364233 |
| 28 | PLK4 | 1.20567303 |
| 29 | AURKA | 1.17996569 |
| 30 | TESK1 | 1.17537127 |
| 31 | CHEK2 | 1.11392324 |
| 32 | CDC7 | 1.10100737 |
| 33 | RPS6KB2 | 1.08875617 |
| 34 | LIMK1 | 1.08555381 |
| 35 | MYLK | 1.06945528 |
| 36 | NEK1 | 1.02809804 |
| 37 | TAOK2 | 1.02169977 |
| 38 | MAP3K10 | 1.01489358 |
| 39 | CDK8 | 1.00100270 |
| 40 | DAPK1 | 0.95630450 |
| 41 | MAP3K12 | 0.94544410 |
| 42 | MAP2K6 | 0.90487719 |
| 43 | SIK1 | 0.90351062 |
| 44 | TSSK6 | 0.90169715 |
| 45 | DAPK3 | 0.89999103 |
| 46 | BLK | 0.89944939 |
| 47 | MUSK | 0.89655268 |
| 48 | CDK12 | 0.88497083 |
| 49 | PRKCI | 0.87968706 |
| 50 | PLK1 | 0.85568403 |
| 51 | CDK4 | 0.84922352 |
| 52 | ILK | 0.84916934 |
| 53 | MAP2K3 | 0.84802631 |
| 54 | IRAK4 | 0.84463580 |
| 55 | RAF1 | 0.84239709 |
| 56 | PDK2 | 0.83782819 |
| 57 | ZAK | 0.82377706 |
| 58 | FLT3 | 0.82227222 |
| 59 | RPS6KA4 | 0.81963035 |
| 60 | PRPF4B | 0.81874462 |
| 61 | CHEK1 | 0.81780437 |
| 62 | EPHA2 | 0.80452965 |
| 63 | MAP2K2 | 0.79114828 |
| 64 | SCYL2 | 0.77821798 |
| 65 | CDK19 | 0.76861730 |
| 66 | CAMK2G | 0.74720171 |
| 67 | IRAK2 | 0.74602266 |
| 68 | STK4 | 0.74330051 |
| 69 | ERN1 | 0.74033961 |
| 70 | AKT2 | 0.73739671 |
| 71 | CDK7 | 0.73590369 |
| 72 | PINK1 | 0.73419725 |
| 73 | AURKB | 0.73200737 |
| 74 | CSNK2A2 | 0.72015375 |
| 75 | CSNK2A1 | 0.71692952 |
| 76 | BRSK2 | 0.71474856 |
| 77 | GRK6 | 0.71463580 |
| 78 | MST1R | 0.71249625 |
| 79 | OBSCN | 0.67107306 |
| 80 | ACVR1B | 0.66409236 |
| 81 | PBK | 0.65408202 |
| 82 | MST4 | 0.65055373 |
| 83 | PHKG1 | 0.64992352 |
| 84 | PHKG2 | 0.64992352 |
| 85 | IRAK1 | 0.64005593 |
| 86 | MAP3K8 | 0.63559074 |
| 87 | PASK | 0.62479955 |
| 88 | RPS6KA5 | 0.62293284 |
| 89 | LRRK2 | 0.61478869 |
| 90 | ZAP70 | 0.59000753 |
| 91 | TTN | 0.57150843 |
| 92 | DYRK2 | 0.56284068 |
| 93 | PAK1 | 0.54939213 |
| 94 | CCNB1 | 0.53975107 |
| 95 | TAF1 | 0.53008760 |
| 96 | MAPK11 | 0.52509848 |
| 97 | CDK11A | 0.52395042 |
| 98 | TTK | 0.51836441 |
| 99 | CDK2 | 0.49552508 |
| 100 | PAK4 | 0.49517840 |
| 101 | MAP4K1 | 0.48805062 |
| 102 | PRKD3 | 0.47365149 |
| 103 | NEK2 | 0.46852625 |
| 104 | PRKG2 | 0.46662948 |
| 105 | MTOR | 0.46624098 |
| 106 | CSNK1G3 | 0.46233563 |
| 107 | CDK15 | 0.44700321 |
| 108 | CDK9 | 0.44465231 |
| 109 | PIK3CG | 0.44251245 |
| 110 | CDK14 | 0.43321980 |
| 111 | BRSK1 | 0.42879861 |
| 112 | CDK1 | 0.41465735 |
| 113 | MAP3K3 | 0.40144926 |
| 114 | MAPK15 | 0.39906844 |
| 115 | CDK18 | 0.39059535 |
| 116 | PIM1 | 0.36343998 |
| 117 | CSNK1A1L | 0.36235573 |
| 118 | ALK | 0.33516050 |
| 119 | MAPK4 | 0.33400206 |
| 120 | TEC | 0.32781009 |
| 121 | RPS6KL1 | 0.32243079 |
| 122 | RPS6KC1 | 0.32243079 |
| 123 | ATM | 0.30300337 |
| 124 | BMX | 0.30160088 |
| 125 | NEK9 | 0.29675142 |
| 126 | CAMK2D | 0.29474179 |
| 127 | TBK1 | 0.29134844 |
| 128 | PLK3 | 0.28896242 |
| 129 | RPS6KA6 | 0.27790686 |
| 130 | ATR | 0.27575096 |
| 131 | BTK | 0.27228183 |
| 132 | PKN2 | 0.26369598 |
| 133 | PNCK | 0.26052031 |
| 134 | MAPKAPK5 | 0.24457194 |
| 135 | CAMK2B | 0.24386268 |
| 136 | PDK3 | 0.24029810 |
| 137 | PDK4 | 0.24029810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.61793189 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.67954917 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.58393822 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.25746503 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.02538251 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.80533999 |
| 7 | Mismatch repair_Homo sapiens_hsa03430 | 2.37054415 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.30847082 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.29751987 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.27416197 |
| 11 | Alzheimers disease_Homo sapiens_hsa05010 | 2.18075454 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.17094106 |
| 13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.07487041 |
| 14 | Sulfur relay system_Homo sapiens_hsa04122 | 2.07295124 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.98986145 |
| 16 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.87586449 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.77850830 |
| 18 | Spliceosome_Homo sapiens_hsa03040 | 1.73647037 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.69231045 |
| 20 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.67470273 |
| 21 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.67427328 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.61168357 |
| 23 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.55458569 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.54423794 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.51364344 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.49354488 |
| 27 | Homologous recombination_Homo sapiens_hsa03440 | 1.44625301 |
| 28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.44168130 |
| 29 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.43276685 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.43229906 |
| 31 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.40409162 |
| 32 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.36644553 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.36112095 |
| 34 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.30027751 |
| 35 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.29648316 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.25634215 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.23453033 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.23282220 |
| 39 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.22915150 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22358166 |
| 41 | RNA transport_Homo sapiens_hsa03013 | 1.18286361 |
| 42 | Purine metabolism_Homo sapiens_hsa00230 | 1.16513651 |
| 43 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.08449837 |
| 44 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.08182671 |
| 45 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.08122459 |
| 46 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04327069 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.02201377 |
| 48 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.94232978 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94112126 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.94092066 |
| 51 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93721432 |
| 52 | Metabolic pathways_Homo sapiens_hsa01100 | 0.93712198 |
| 53 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.93420313 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91170399 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.90873096 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90636278 |
| 57 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.90343589 |
| 58 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.89341456 |
| 59 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89309373 |
| 60 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.88925018 |
| 61 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.85630454 |
| 62 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.82904906 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82785477 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.81495262 |
| 65 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79955412 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.78764566 |
| 67 | RNA degradation_Homo sapiens_hsa03018 | 0.78222736 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76925275 |
| 69 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76738798 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74174863 |
| 71 | Bladder cancer_Homo sapiens_hsa05219 | 0.73936135 |
| 72 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71354697 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.69777125 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.67842648 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.65898183 |
| 76 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64839385 |
| 77 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61307373 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.54701038 |
| 79 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.51846161 |
| 80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.51793208 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.51279467 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.49533965 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46969296 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45644786 |
| 85 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45309361 |
| 86 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43519411 |
| 87 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.43477308 |
| 88 | Cell cycle_Homo sapiens_hsa04110 | 0.43303835 |
| 89 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42804070 |
| 90 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42054790 |
| 91 | Shigellosis_Homo sapiens_hsa05131 | 0.40631321 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.40009940 |
| 93 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37728585 |
| 94 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.35909239 |
| 95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.35212306 |
| 96 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.34792028 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33146788 |
| 98 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.32769923 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.32218175 |
| 100 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32028727 |
| 101 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.31662762 |
| 102 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.30955067 |
| 103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.30744219 |
| 104 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.30240690 |
| 105 | Apoptosis_Homo sapiens_hsa04210 | 0.28815652 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.28141133 |
| 107 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.27813048 |
| 108 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.27189851 |
| 109 | Other glycan degradation_Homo sapiens_hsa00511 | 0.23867589 |
| 110 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.23306711 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.23183907 |
| 112 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.22984008 |
| 113 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.22937484 |
| 114 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.22366463 |
| 115 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.21910418 |
| 116 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.21434093 |
| 117 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.20718959 |
| 118 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.20376100 |
| 119 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18963117 |
| 120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17490471 |
| 121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.16059113 |
| 122 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.16025131 |
| 123 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.15037426 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.12022301 |
| 125 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.09825234 |

